Clinical trials
Completed Phase 1 Urogenital Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 2 |
| Advaxis, Inc. | 1 |
| Aragon Pharmaceuticals, Inc. | 1 |
| IGF Oncology, LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Pharmacyclics LLC. | 1 |
| Tesaro, Inc. | 1 |
| Virginia Commonwealth University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 9 |
| Breast Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Neoplasms | 4 |
| Brain Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Gastrointestinal Neoplasms | 3 |
| Genital Diseases, Male | 3 |
| Head and Neck Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.